Skip to Main Content
Back to News

NUTANIX Earnings Results: $NTNX Reports Quarterly Earnings

None

NUTANIX ($NTNX) posted quarterly earnings results on Wednesday, May 28th. The company reported earnings of $0.42 per share, beating estimates of $0.39 by $0.03. The company also reported revenue of $638,980,000, beating estimates of $638,518,898 by $461,102.

You can see Quiver Quantitative's $NTNX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

NUTANIX Insider Trading Activity

NUTANIX insiders have traded $NTNX stock on the open market 13 times in the past 6 months. Of those trades, 0 have been purchases and 13 have been sales.

Here’s a breakdown of recent trading of $NTNX stock by insiders over the last 6 months:

  • GROEN MAX PIETER DE sold 5,500,000 shares for an estimated $409,805,000
  • RAJIV RAMASWAMI (President and CEO) has made 0 purchases and 5 sales selling 228,550 shares for an estimated $16,321,669.
  • RUKMINI SIVARAMAN (Chief Financial Officer) has made 0 purchases and 5 sales selling 14,625 shares for an estimated $981,671.
  • STEVEN J GOMO sold 7,000 shares for an estimated $533,146
  • VIRGINIA GAMBALE sold 6,060 shares for an estimated $392,278

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

NUTANIX Hedge Fund Activity

We have seen 355 institutional investors add shares of NUTANIX stock to their portfolio, and 253 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

NUTANIX Congressional Stock Trading

Members of Congress have traded $NTNX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $NTNX stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

NUTANIX Analyst Ratings

Wall Street analysts have issued reports on $NTNX in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Morgan Stanley issued a "Overweight" rating on 05/20/2025
  • RBC Capital issued a "Outperform" rating on 03/02/2025
  • Barclays issued a "Overweight" rating on 02/27/2025

To track analyst ratings and price targets for NUTANIX, check out Quiver Quantitative's $NTNX forecast page.

NUTANIX Price Targets

Multiple analysts have issued price targets for $NTNX recently. We have seen 2 analysts offer price targets for $NTNX in the last 6 months, with a median target of $88.5.

Here are some recent targets:

  • An analyst from Barclays set a target price of $94.0 on 02/27/2025
  • An analyst from Raymond James set a target price of $83.0 on 02/27/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles